World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02232269
Date of registration: 28/08/2014
Prospective Registration: No
Primary sponsor: Lawson Health Research Institute
Public title: Coffee Interaction With the Antihypertensive Drug Felodipine
Scientific title: Phase 1 Study of the Hemodynamic and Pharmacokinetic Interactions Between Coffee and Felodipine
Date of first enrolment: February 2012
Target sample size: 13
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02232269
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  Phase 1
Countries of recruitment
Canada
Contacts
Name:     David G Bailey, BScPhm, PhD
Address: 
Telephone:
Email:
Affiliation:  Lawson Health Research Institute
Key inclusion & exclusion criteria

Inclusion Criteria:

- healthy (normal physical exam, blood clinical chemistry)

- willingly signs ethics approved informed consent form

Exclusion Criteria:

- history of cardiac, renal, hepatic or gastrointestinal disease or substance abuse

- significant illness within 2 weeks of starting study

- history of allergy to felodipine , tablet ingredients or dihydropyridines

- routinely taking prescription or OTC drugs or natural health products

- received an investigational drug withing the previous 4 weeks

- females who are pregnant or breast-feeding



Age minimum: 30 Years
Age maximum: 65 Years
Gender: All
Health Condition(s) or Problem(s) studied
Food-Drug Interactions
Intervention(s)
Other: Black Coffee
Drug: Felodipine
Other: Grapefruit Juice
Other: Water
Primary Outcome(s)
The effect of felodipine on coffee-mediated increases in peripheral and central blood pressure . [Time Frame: Change from Baseline to 8 hours Post Dose]
Secondary Outcome(s)
The effect of coffee on the oral pharmacokinetics of felodipine. [Time Frame: Change from Baseline to 8 hours Post Dose]
Secondary ID(s)
NA-7122
R-11-655
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history